Evidence map›Paper›PMID 22895184›Full record

ArticleCell cycle (Georgetown, Tex.)2012

Overexpression of a novel osteopetrosis-related gene CCDC154 suppresses cell proliferation by inducing G2/M arrest.

Wanqin Liao, Rongsen Zhao, Liting Lu, Rongrong Zhang, Jiawei Zou, Tao Xu, Changjie Wu, Jiajia Tang, Yuezhen Deng, Xincheng Lu

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Proteomics Investigation of the Impact of theInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Enhanced expression of queuine tRNA-ribosyltransferase 1 (Annals of translational medicine · 2020
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Wanqin LiaoInstitute of Genomic Medicine, Wenzhou Medical College, Wenzhou, China.
Rongsen Zhao
Liting Lu
Rongrong Zhang
Jiawei Zou
Tao Xu
Changjie Wu
Jiajia Tang
Yuezhen Deng
Xincheng Lu
Wenzhou Medical University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteopetrosis, a disorder of skeletal bone, can cause death during childhood. We previously described a new spontaneous autosomal recessive osteopetrosis mouse mutant, "new toothless" (ntl). In this study, we reported for the first time the identification, cloning and characterization of the coiled-coil domain-containing 154 (CCDC154), a novel gene whose deletion of ~5 kb sequence including exons 1-6 was completely linked to the ntl mutant. The CCDC154 was conserved between mouse and human and is wildly expressed in mouse tissues. The cellular localization of CCDC154 was in the early endosomes. Overexpression of CCDC154 inhibited cell proliferation of HEK293 cells by inducing G 2/M arrest. CCDC154 also inhibited tumor cell growth, and the soft agar assay revealed a significant decrease of the colony size of Hela cells upon transfection of CCDC154. Our results indicate that CCDC154 is a novel osteopetrosis-related gene involved in cell cycle regulation and tumor suppression growth.

Indexed as

Models, MolecularAmino Acid SequenceAnimalsBase SequenceCell Cycle ProteinsCell ProliferationDNA PrimersEndosomesG2 Phase Cell Cycle CheckpointsHEK293 CellsHeLa CellsHumansMiceMicroscopy, FluorescenceMolecular Sequence DataOsteopetrosisCCDC154 protein, humanCell Cycle ProteinsDNA PrimersTumor Suppressor Proteins

Identifiers

PMID22895184
PMCPMC3466526
OpenAlexW2015627564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.